Ausgabe 3/2011
Inhalt (35 Artikel)
Cumulative cost of prescription medication in outpatients with type 1 diabetes in Finland
R. Lithovius, V. Harjutsalo, C. Forsblom, P. H. Groop
Cardiovascular risk factors in children exposed to maternal diabetes in utero
N. A. West, T. L. Crume, M. A. Maligie, D. Dabelea
Rapid increase in the incidence of type 1 diabetes in Polish children from 1989 to 2004, and predictions for 2010 to 2025
P. Jarosz-Chobot, J. Polanska, A. Szadkowska, A. Kretowski, E. Bandurska-Stankiewicz, M. Ciechanowska, G. Deja, M. Mysliwiec, J. Peczynska, J. Rutkowska, A. Sobel-Maruniak, P. Fichna, A. Chobot, M. Rewers
Fecundability among women with type 1 and type 2 diabetes in the Norwegian Mother and Child Cohort Study
K. W. Whitworth, D. D. Baird, L. C. Stene, R. Skjaerven, M. P. Longnecker
Cardiovascular disease, heart failure, chronic kidney disease and depression independently increase the risk of incident diabetes
G. A. Nichols, E. J. Moler
Cancer in patients admitted to hospital with diabetes mellitus aged 30 years and over: record linkage studies
C. J. Wotton, D. G. R. Yeates, M. J. Goldacre
Association testing of TCF7L2 polymorphisms with type 2 diabetes in multi-ethnic youth
D. Dabelea, L. M. Dolan, R. D’Agostino Jr, A. M. Hernandez, J. B. McAteer, R. F. Hamman, E. J. Mayer-Davis, S. Marcovina, J. M. Lawrence, C. Pihoker, J. C. Florez
A novel surrogate index for hepatic insulin resistance
J. Vangipurapu, A. Stančáková, T. Kuulasmaa, J. Paananen, J. Kuusisto, E. Ferrannini, M. Laakso
Genetic associations in diabetic nephropathy: a meta-analysis
A. L. Mooyaart, E. J. J. Valk, L. A. van Es, J. A. Bruijn, E. de Heer, B. I. Freedman, O. M. Dekkers, H. J. Baelde
Decreased insulin secretion and increased risk of type 2 diabetes associated with allelic variations of the WFS1 gene: the Data from Epidemiological Study on the Insulin Resistance Syndrome (DESIR) prospective study
N. Cheurfa, G. M. Brenner, A. F. Reis, D. Dubois-Laforgue, R. Roussel, J. Tichet, O. Lantieri, B. Balkau, F. Fumeron, J. Timsit, M. Marre, G. Velho
Association of indices of liver and adipocyte insulin resistance with 19 confirmed susceptibility loci for type 2 diabetes in 6,733 non-diabetic Finnish men
J. Vangipurapu, A. Stančáková, J. Pihlajamäki, T. M. Kuulasmaa, T. Kuulasmaa, J. Paananen, J. Kuusisto, E. Ferrannini, M. Laakso
Glucose stimulates human beta cell replication in vivo in islets transplanted into NOD–severe combined immunodeficiency (SCID) mice
H. E. Levitt, T. J. Cyphert, J. L. Pascoe, D. A. Hollern, N. Abraham, R. J. Lundell, T. Rosa, L. C. Romano, B. Zou, C. P. O’Donnell, A. F. Stewart, A. Garcia-Ocaña, L. C. Alonso
Mafa expression enhances glucose-responsive insulin secretion in neonatal rat beta cells
C. Aguayo-Mazzucato, A. Koh, I. El Khattabi, W.-C. Li, E. Toschi, A. Jermendy, K. Juhl, K. Mao, G. C. Weir, A. Sharma, S. Bonner-Weir
Rat neonatal beta cells lack the specialised metabolic phenotype of mature beta cells
A. Jermendy, E. Toschi, T. Aye, A. Koh, C. Aguayo-Mazzucato, A. Sharma, G. C. Weir, D. Sgroi, S. Bonner-Weir
Dissociation of lipotoxicity and glucotoxicity in a mouse model of obesity associated diabetes: role of forkhead box O1 (FOXO1) in glucose-induced beta cell failure
O. Kluth, F. Mirhashemi, S. Scherneck, D. Kaiser, R. Kluge, S. Neschen, H.-G. Joost, A. Schürmann
TNF-α acutely upregulates amylin expression in murine pancreatic beta cells
K. Cai, D. Qi, O. Wang, J. Chen, X. Liu, B. Deng, L. Qian, X. Liu, Y. Le
The Trial to Reduce IDDM in the Genetically at Risk (TRIGR) study: recruitment, intervention and follow-up
H. K. Åkerblom
Extended evaluation of the safety and efficacy of GAD treatment of children and adolescents with recent-onset type 1 diabetes: a randomised controlled trial
J. Ludvigsson, M. Hjorth, M. Chéramy, S. Axelsson, M. Pihl, G. Forsander, N.-Ö. Nilsson, B.-O. Samuelsson, T. Wood, J. Åman, E. Örtqvist, R. Casas
Increased prevalence of non-alcoholic fatty liver disease in European women with a history of gestational diabetes
S. Forbes, S. D. Taylor-Robinson, N. Patel, P. Allan, B. R. Walker, D. G. Johnston
Postprandial hyperaminoacidaemia overcomes insulin resistance of protein anabolism in men with type 2 diabetes
M. Bassil, E. B. Marliss, J. A. Morais, S. Pereira, S. Chevalier, R. Gougeon
Diabetes-induced peroxynitrite impairs the balance of pro-nerve growth factor and nerve growth factor, and causes neurovascular injury
T. K. Ali, M. M. H. Al-Gayyar, S. Matragoon, B. A. Pillai, M. A. Abdelsaid, J. J. Nussbaum, A. B. El-Remessy
Epicatechin blocks pro-nerve growth factor (proNGF)-mediated retinal neurodegeneration via inhibition of p75 neurotrophin receptor proNGF expression in a rat model of diabetes
M. M. H. Al-Gayyar, S. Matragoon, B. A. Pillai, T. K. Ali, M. A. Abdelsaid, A. B. El-Remessy
Delayed intervention with AGE inhibitors attenuates the progression of diabetes-accelerated atherosclerosis in diabetic apolipoprotein E knockout mice
A. M. D. Watson, A. Soro-Paavonen, K. Sheehy, J. Li, A. C. Calkin, A. Koitka, S. N. Rajan, D. Brasacchio, T. J. Allen, M. E. Cooper, M. C. Thomas, K. J. A. Jandeleit-Dahm
Müller glial dysfunction during diabetic retinopathy in rats is linked to accumulation of advanced glycation end-products and advanced lipoxidation end-products
T. M. Curtis, R. Hamilton, P.-H. Yong, C. M. McVicar, A. Berner, R. Pringle, K. Uchida, R. Nagai, S. Brockbank, A. W. Stitt
Anti-CCL3 autoantibodies are not markers of type 1 diabetes when measured by a commercial ELISA method
A. G. Ziegler, U. Mollenhauer, P. Achenbach, E. Bonifacio
Intensified glucose lowering in type 2 diabetes: time for a bolder reappraisal
L. Czupryniak, E. Szymańska-Garbacz, M. Pawłowski, M. Saryusz-Wolska, J. Loba
Intensified glucose lowering in type 2 diabetes: don’t throw the baby out with the bathwater
J. H. DeVries
Intensified glucose lowering in type 2 diabetes. Reply to Czupryniak L, Szymańska-Garbacz E, Pawłowski M et al. [letter], Aizawa T and Funase Y [letter] and DeVries JH [letter]
J. S. Yudkin, B. Richter, E. A. M. Gale
Meta-analysis of trial data may support a causal role of hyperglycaemia in cancer
X. L. Yang, R. C. W. Ma, J. C. N. Chan
Meta-analysis of trial data may support a causal role of hyperglycaemia in cancer. Reply to Yang XL, Ma RCW, Chan JCN [letter]
J. A. Johnson, S. L. Bowker
Erratum: Epicatechin blocks pro-nerve growth factor (proNGF)-mediated retinal neurodegeneration via inhibition of p75 neurotrophin receptor expression in a rat model of diabetes
M. M. H. Al-Gayyar, S. Matragoon, B. A. Pillai, T. K. Ali, M. A. Abdelsaid, A. B. El-Remessy